BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22343747)

  • 1. Activation of receptor protein-tyrosine kinases from the cytoplasmic compartment.
    Yamanashi Y; Tezuka T; Yokoyama K
    J Biochem; 2012 Apr; 151(4):353-9. PubMed ID: 22343747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
    Hamuro J; Higuchi O; Okada K; Ueno M; Iemura S; Natsume T; Spearman H; Beeson D; Yamanashi Y
    J Biol Chem; 2008 Feb; 283(9):5518-24. PubMed ID: 18165682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carboxyl-terminal region of Dok-7 plays a key, but not essential, role in activation of muscle-specific receptor kinase MuSK and neuromuscular synapse formation.
    Ueta R; Tezuka T; Izawa Y; Miyoshi S; Nagatoishi S; Tsumoto K; Yamanashi Y
    J Biochem; 2017 Mar; 161(3):269-277. PubMed ID: 28069867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation.
    Inoue A; Setoguchi K; Matsubara Y; Okada K; Sato N; Iwakura Y; Higuchi O; Yamanashi Y
    Sci Signal; 2009 Feb; 2(59):ra7. PubMed ID: 19244212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.
    Okada K; Inoue A; Okada M; Murata Y; Kakuta S; Jigami T; Kubo S; Shiraishi H; Eguchi K; Motomura M; Akiyama T; Iwakura Y; Higuchi O; Yamanashi Y
    Science; 2006 Jun; 312(5781):1802-5. PubMed ID: 16794080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overview: MuSK/Dok-7].
    Motomura M; Fukuda T; Yoshimura T; Tsujihata M
    Nihon Rinsho; 2008 Jun; 66(6):1140-8. PubMed ID: 18540360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase- and rapsyn-independent activities of the muscle-specific kinase (MuSK).
    Bromann PA; Zhou H; Sanes JR
    Neuroscience; 2004; 125(2):417-26. PubMed ID: 15062984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor tyrosine kinases: from biology to pathology.
    Choura M; Rebaï A
    J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling receptor tyrosine kinases to Rho GTPases--GEFs what's the link.
    Schiller MR
    Cell Signal; 2006 Nov; 18(11):1834-43. PubMed ID: 16725310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
    Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tetratricopeptide repeat domains of rapsyn bind directly to cytoplasmic sequences of the muscle-specific kinase.
    Antolik C; Catino DH; Resneck WG; Bloch RJ
    Neuroscience; 2006 Aug; 141(1):87-100. PubMed ID: 16675143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization.
    Bergamin E; Hallock PT; Burden SJ; Hubbard SR
    Mol Cell; 2010 Jul; 39(1):100-9. PubMed ID: 20603078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent.
    Castagnino P; Biesova Z; Wong WT; Fazioli F; Gill GN; Di Fiore PP
    Oncogene; 1995 Feb; 10(4):723-9. PubMed ID: 7532293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytohesins are cytoplasmic ErbB receptor activators.
    Bill A; Schmitz A; Albertoni B; Song JN; Heukamp LC; Walrafen D; Thorwirth F; Verveer PJ; Zimmer S; Meffert L; Schreiber A; Chatterjee S; Thomas RK; Ullrich RT; Lang T; Famulok M
    Cell; 2010 Oct; 143(2):201-11. PubMed ID: 20946980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
    Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
    Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase receptors as attractive targets of cancer therapy.
    Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of extracellular signal-regulated kinase activity by p120 RasGAP does not involve its pleckstrin homology or calcium-dependent lipid binding domains but does require these domains to regulate cell proliferation.
    Koehler JA; Moran MF
    Cell Growth Differ; 2001 Nov; 12(11):551-61. PubMed ID: 11714636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.